News on May 12thLaunchpadenjinstarterThere are seven advantages that may affect tomorrow's stock market, specifically:

1. China Industrial International: the subsidiary signed 1LaunchpadenjinstarterPurchase project contract of .08 billion yuan

Sinogong International (002051) announced on the evening of May 12th that the company's wholly-owned subsidiary Beijing hoisting and Transportation Machinery Design and Research Institute Co., Ltd. signed with North Huajin United Petrochemical Co., Ltd.LaunchpadenjinstarterThe fine chemical and raw material engineering project-finished product packaging and warehouse automation three-dimensional warehouse equipment procurement project. According to the contract, the purchase contract amount of the project is 1.Launchpadenjinstarter.08 billion yuan.

2. Dalian ship signed 10 sets of 24000TEU LNG dual-fuel container ship propeller purchase and sale contract

China heavy Industry (rights protection) news, recently, Dalian Shipbuilding, a subsidiary of China Shipbuilding Group, successfully signed a contract for the purchase and sale of propellers for 10 sets of 24000TEU LNG dual-fuel container ships, with a total contract amount of more than 100 million yuan, breaking the situation that the propeller of the container ship has been monopolized by foreign propeller manufacturers for a long time. The propeller design of the project is designed by a joint venture between Dalian ship and 702, with 5 leaves, 10.5 meters in diameter and a product weight of about 96.32 tons. The first oar is scheduled to be delivered in August 2025.

3. China Auto Research: the construction of the National Automobile Network Information Security Product quality Inspection Center has been basically completed.

China Auto Research said in an institutional survey on May 11 that the national vehicle network information security product quality inspection and testing center to be built by the company has been basically completed, waiting to be raised, and its main capabilities are focused on network security and data security. At present, China Auto Research has obtained more than 10 qualifications authorized by CNAS (China National Accreditation Committee for conformity Assessment). Have the ability to cover the whole vehicle and key parts network security management system construction, product R & D consultation, verification and regulation evaluation and certification. Have the ability to build and evaluate the safety management system of automobile data in the whole life cycle; have the ability of personal information security protection, privacy compliance and data exit compliance evaluation and certification services Can carry out vehicle and parts threat analysis and risk assessment, vehicle and parts communication safety testing, penetration testing, side channel analysis and fault injection, legal collection of personal information, automobile data safety compliance sharing and automobile data exit compliance evaluation and other services.

4. Zhongman Petroleum: won the bid for the development rights of oil and gas blocks in Iraq.

Sinopec (603619) announced on the evening of May 12th that on May 11th, the company participated in the fifth (+) round and the sixth round of oil and gas block bidding of the Iraqi Ministry of Oil, and successfully won the development rights of Iraq's East Baghdad Field Northern Extension block (referred to as "EBN block") and Middle Euphrates block (referred to as "MF block"). The EBN bloc is located in the provinces of Baghdad and Salahuddin in central Iraq, covering an area of 231 square kilometers. The MF block is located in Najaf and Karbala provinces in central Iraq, covering an area of 1073 square kilometers.

5. East China Pharmaceutical: the subsidiary company received the notice of acceptance of the application for listing license of Maihuatinib tablets.

East China Pharmaceutical (000963) announced on the evening of May 12th that the wholly owned subsidiary of China, America and East China received the "acceptance notice" issued by the State Drug Administration. The application for first-line treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) adult patients with epidermal growth factor receptor (EGFR) exon 21 L858R replacement mutation of Maihuatinib tablets (trade name: Miraidong ®) declared by Central American East China as the applicant has been accepted.

6. Baicheng Pharmaceutical: the subsidiary company received the notice of approval for clinical trials of BIOS2207 drugs.

Baicheng Pharmaceutical (301096) announced on the evening of May 12th that Zhejiang Semer Pharmaceutical Co., Ltd., a wholly owned subsidiary, recently received a notice of clinical trial approval from the State Drug Administration. BIOS2207, a drug independently developed by the company, will conduct clinical trials. The indication of BIOS2207 is the treatment of adults and children aged 4 years and above with partial seizures (with or without secondary generalized seizures).

7. Pulit: the subsidiary Haisida has signed a contract for the purchase and sale of sodium ion batteries not lower than 1.5GWh.

Pulit (002324) announced on the evening of May 12th that the holding subsidiary Haisida recently signed a framework contract with Shanghai Hirano for the purchase and sale of sodium battery products not less than 1.5GWh, which will be delivered in batches from May 2024 to December 2026, and the products will eventually be mainly used in the world's well-known electric forklifts, low-speed vehicles, functional vehicles and other fields. The two sides will make use of their respective advantages and work closely together to develop the global special vehicle market.